APOE ε4 is associated with higher levels of CSF SNAP-25 in prodromal Alzheimer’s disease
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 01, 2018
- Source ID
- 10.1016/j.neulet.2018.08.029
Entities
People
- Jie Zhang
- Shanshan Wang
- Tengwei Pan
Organizations
- AbbVie
- Alzheimer's Association
- Alzheimer's Disease Neuroimaging Initiative
- Alzheimer's Drug Discovery Foundation
- BioClinica
- Biogen
- Bristol-Myers Squibb
- Canadian Institutes of Health Research
- Chiron Corporation
- Eli Lilly and Company
- GE HealthCare
- Hoffmann-La Roche
- Johnson & Johnson Pharmaceutical Research and Development
- Laboratoires Servier
- Lundbeck
- Merck & Co.
- Meso Scale Diagnostics (United States)
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- Pfizer
- Roche (United States)
- Takeda Pharmaceutical Company